Medicare Enrolled

Dr. Srisha Rao, M.D.

Cardiovascular Disease · Ocala, FL
Practice pattern: Cardiac & Remote — Practice combining cardiac and remote services
2111 SW 20TH PL, Ocala, FL 34471
3526224251
Registered in NPPES since 2005
NPI: 1578548970 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rao

Dr. Srisha Rao is a cardiovascular disease specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 14,762 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rao received a total of $8,691 from 38 pharmaceutical and/or device companies across 357 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in FL $8,691 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 73544 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
14,762
Medicare services
Top 3% in FL for cardiovascular disease
Not available
Unique patients (not deduplicated)
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
2,787 $89 $233
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
1,636 $43 $108
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,537 $61 $160
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
1,379 $122 $354
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 772 $312 $800
Remote pacemaker/defibrillator monitoring, 90 days
Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check.
719 $15 $49
Remote pacemaker monitoring, 90 days
Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart.
551 $20 $62
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
493 $4 $11
Anticoagulant management for warfarin
Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen.
478 $8 $24
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
459 $53 $142
Remote monitoring of implantable heart rhythm device
Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days.
459 $28 $71
Nuclear stress test with CT scan
A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan.
386 $2,059 $4,835
PET scan of heart muscle blood flow
A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle.
383 $139 $342
Pacemaker programming, dual lead system
Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings.
341 $54 $141
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
262 $10 $36
Remote monitoring of implantable heart device, up to 30 days
Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days.
253 $20 $53
Remote cardiac rhythm monitor evaluation, up to 30 days
Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days.
212 $20 $53
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
209 $104 $275
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
192 $63 $149
Remote evaluation of implantable defibrillator system
Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation.
172 $24 $98
Physician review of home INR testing
A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria.
163 $7 $19
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
145 $101 $332
Technetium Tc-99m tetrofosmin diagnostic injection
A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies.
124 $170 $215
2-day continuous ECG with review and report
A two-day continuous electrocardiogram recording that includes a professional review and written report of the results.
115 $47 $164
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
106 $71 $220
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
63 $325 $898
Pacemaker programming, single lead
Adjustment and testing of a single-lead pacemaker to ensure it functions correctly.
58 $48 $121
Programming of dual lead implantable defibrillator system
Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function.
58 $63 $180
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
55 $40 $82
Programming of multiple lead implantable defibrillator system
Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function.
53 $77 $194
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
47 $20 $52
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $125 $320
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
19 $63 $202
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
18 $140 $394
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $138 $360
Cardiac rhythm monitor evaluation
Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity.
12 $38 $72
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.6% high complexity
18.2% medium
59.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,691
Total received (2018-2024)
Avg $1,242/year across 7 years
Top 28% in FL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
357
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,684
2023
$1,695
2022
$1,586
2021
$1,393
2020
$569
2019
$664
2018
$1,100

Payments by company (2024)

ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$230
PFIZER INC.
$186
Kestra Medical Technology Services, Inc.
$167
Boston Scientific Corporation
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Lexicon Pharmaceuticals, Inc.
$148
CVRx, Inc.
$125
Merck Sharp & Dohme LLC
$87
Amgen Inc.
$67
Novartis Pharmaceuticals Corporation
$64
AstraZeneca Pharmaceuticals LP
$52
Janssen Pharmaceuticals, Inc
$49
Alnylam Pharmaceuticals Inc.
$39
Regeneron Healthcare Solutions, Inc.
$32
Esperion Therapeutics, Inc.
$30
Philips North America LLC
$23
Impulse Dynamics (USA) Inc.
$22
Abbott Laboratories
$20
ATRICURE, INC.
$19
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$990
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$867
Janssen Pharmaceuticals, Inc
$770
Novartis Pharmaceuticals Corporation
$618
Boston Scientific Corporation
$530
Impulse Dynamics (USA) Inc.
$466
Abbott Laboratories
$387
Amarin Pharma Inc.
$381
Boehringer Ingelheim Pharmaceuticals, Inc.
$358
Amgen Inc.
$355
AstraZeneca Pharmaceuticals LP
$317
Merck Sharp & Dohme LLC
$286
Stryker Corporation
$253
E.R. Squibb & Sons, L.L.C.
$234
Lexicon Pharmaceuticals, Inc.
$222
BIOTRONIK INC.
$185
Kestra Medical Technology Services, Inc.
$167
Alnylam Pharmaceuticals Inc.
$157
Astellas Pharma US Inc
$154
Philips Electronics North America Corporation
$146
CVRx, Inc.
$143
SANOFI-AVENTIS U.S. LLC
$109
Esperion Therapeutics, Inc.
$88
ATRICURE, INC.
$83
Medtronic, Inc.
$57
Allergan Inc.
$55
Regeneron Healthcare Solutions, Inc.
$47
Medtronic Vascular, Inc.
$45
BOSTON SCIENTIFIC CORPORATION
$32
Novo Nordisk Inc
$30
Merck Sharp & Dohme Corporation
$29
Edwards Lifesciences Corporation
$24
Philips North America LLC
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
AngioDynamics, Inc.
$17
ARALEZ PHARMACEUTICALS US INC.
$16
Cleerly, Inc.
$15
Lundbeck LLC
$13
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · ATRICLIP LAA EXCLUSION SYSTEM · Acticor · Armada 35 percutaneous catheter · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · Claria MRI · Cleerly Labs · Corlanor · DUPIXENT · ELIQUIS · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · Inpefa · JARDIANCE · JOT DX · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-DX · LifeVest · MAKO · MITRACLIP · MULTAQ · NEXLETOL · NORTHERA · No Associated Product · ONPATTRO · Optimizer · Optimizer Smart System · Ozempic · PK Papyrus · PRADAXA · PRALUENT · RYBELSUS · Repatha · SQRX PULSE GENERATOR · Spectranetics Undiv · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · VenaCure 1470 Pro · WATCHMAN · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cardiovascular disease specialist in Ocala?
Compare cardiologists in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists in nearby ZIP areas
53
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rao is a cardiac & remote specialist, with above-average Medicare volume (top 3% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rao performed 2,787 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $8,691 from 38 companies across 357 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other cardiologists in Ocala?
Dr. Rao's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →